MedTrace Logo

Investigation on the Benefits of Avoiding Conventional Food Packaging and Promoting Bioplastic Food Packaging

NCT04963842 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2022-09-28

No results posted yet for this study

Summary

A trial study was proposed as part of the project "Biocomposite Packaging for Active Preservation of Food" (acronym BIOFOODPACK) that has been funded by the M-ERA.Net Call 2016. A crossover trial with a behavioral intervention study will be conducted. The behavioural intervention treatment consists of: i) avoiding the consumption of packaged (cans, plastic, paper) ready to consume foods, and foods from take away/delivery/fast food, and ii) using the proposed bio-based packaging material to package foods ready for consumption; this bio-based packaging material (Silvex Ltd, Portugal) does not contain plasticizers, it is biodegradable and made out of plant-based materials (corn, starch, etc.). The objectives of this study are:

1. To describe the body burden of plasticizers for women aged 18-40 years systematically adopting the intervention treatment package during the 5-day period.
2. To assess the diurnal variability of the plasticizers, based on regular daily activities of the young adult women.

Conditions

  • Dietary Exposure

Interventions

BEHAVIORAL

Use of bio-plastic food packaging material and avoidance of plastic food packaging material

The bio-plastic food packaging material will be used by the study participants for 5 days and no plastic packaged food will be consumed.

Sponsors & Collaborators

  • Cyprus University of Technology

    lead OTHER

Principal Investigators

  • Konstantinos Makris, PhD · Cyprus University of Technology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-15
Primary Completion
2022-08-05
Completion
2022-08-05

Countries

  • Cyprus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04963842 on ClinicalTrials.gov